Chapter/Section Purchase

1 Study Coverage
1.1 Devices for Inhaled Medications Product Introduction
1.2 Market by Type
1.2.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dry Powder Inhalers
1.2.3 Metered-Dose Inhalers
1.2.4 Nebulizers
1.2.5 Soft Mist Inhaler
1.3 Market by Application
1.3.1 Global Devices for Inhaled Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Devices for Inhaled Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Devices for Inhaled Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Devices for Inhaled Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Devices for Inhaled Medications Sales by Region
2.4.1 Global Devices for Inhaled Medications Sales by Region (2017-2022)
2.4.2 Global Sales Devices for Inhaled Medications by Region (2023-2028)
2.5 Global Devices for Inhaled Medications Revenue by Region
2.5.1 Global Devices for Inhaled Medications Revenue by Region (2017-2022)
2.5.2 Global Devices for Inhaled Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Devices for Inhaled Medications Sales by Manufacturers
3.1.1 Global Top Devices for Inhaled Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Devices for Inhaled Medications in 2021
3.2 Global Devices for Inhaled Medications Revenue by Manufacturers
3.2.1 Global Devices for Inhaled Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Devices for Inhaled Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Devices for Inhaled Medications Revenue in 2021
3.3 Global Devices for Inhaled Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Devices for Inhaled Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Devices for Inhaled Medications Sales by Type
4.1.1 Global Devices for Inhaled Medications Historical Sales by Type (2017-2022)
4.1.2 Global Devices for Inhaled Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Devices for Inhaled Medications Sales Market Share by Type (2017-2028)
4.2 Global Devices for Inhaled Medications Revenue by Type
4.2.1 Global Devices for Inhaled Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Devices for Inhaled Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Devices for Inhaled Medications Revenue Market Share by Type (2017-2028)
4.3 Global Devices for Inhaled Medications Price by Type
4.3.1 Global Devices for Inhaled Medications Price by Type (2017-2022)
4.3.2 Global Devices for Inhaled Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Devices for Inhaled Medications Sales by Application
5.1.1 Global Devices for Inhaled Medications Historical Sales by Application (2017-2022)
5.1.2 Global Devices for Inhaled Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Devices for Inhaled Medications Sales Market Share by Application (2017-2028)
5.2 Global Devices for Inhaled Medications Revenue by Application
5.2.1 Global Devices for Inhaled Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Devices for Inhaled Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Devices for Inhaled Medications Revenue Market Share by Application (2017-2028)
5.3 Global Devices for Inhaled Medications Price by Application
5.3.1 Global Devices for Inhaled Medications Price by Application (2017-2022)
5.3.2 Global Devices for Inhaled Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Devices for Inhaled Medications Market Size by Type
6.1.1 North America Devices for Inhaled Medications Sales by Type (2017-2028)
6.1.2 North America Devices for Inhaled Medications Revenue by Type (2017-2028)
6.2 North America Devices for Inhaled Medications Market Size by Application
6.2.1 North America Devices for Inhaled Medications Sales by Application (2017-2028)
6.2.2 North America Devices for Inhaled Medications Revenue by Application (2017-2028)
6.3 North America Devices for Inhaled Medications Market Size by Country
6.3.1 North America Devices for Inhaled Medications Sales by Country (2017-2028)
6.3.2 North America Devices for Inhaled Medications Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Devices for Inhaled Medications Market Size by Type
7.1.1 Europe Devices for Inhaled Medications Sales by Type (2017-2028)
7.1.2 Europe Devices for Inhaled Medications Revenue by Type (2017-2028)
7.2 Europe Devices for Inhaled Medications Market Size by Application
7.2.1 Europe Devices for Inhaled Medications Sales by Application (2017-2028)
7.2.2 Europe Devices for Inhaled Medications Revenue by Application (2017-2028)
7.3 Europe Devices for Inhaled Medications Market Size by Country
7.3.1 Europe Devices for Inhaled Medications Sales by Country (2017-2028)
7.3.2 Europe Devices for Inhaled Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Devices for Inhaled Medications Market Size by Type
8.1.1 Asia Pacific Devices for Inhaled Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Devices for Inhaled Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Devices for Inhaled Medications Market Size by Application
8.2.1 Asia Pacific Devices for Inhaled Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Devices for Inhaled Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Devices for Inhaled Medications Market Size by Region
8.3.1 Asia Pacific Devices for Inhaled Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Devices for Inhaled Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Devices for Inhaled Medications Market Size by Type
9.1.1 Latin America Devices for Inhaled Medications Sales by Type (2017-2028)
9.1.2 Latin America Devices for Inhaled Medications Revenue by Type (2017-2028)
9.2 Latin America Devices for Inhaled Medications Market Size by Application
9.2.1 Latin America Devices for Inhaled Medications Sales by Application (2017-2028)
9.2.2 Latin America Devices for Inhaled Medications Revenue by Application (2017-2028)
9.3 Latin America Devices for Inhaled Medications Market Size by Country
9.3.1 Latin America Devices for Inhaled Medications Sales by Country (2017-2028)
9.3.2 Latin America Devices for Inhaled Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Devices for Inhaled Medications Market Size by Type
10.1.1 Middle East and Africa Devices for Inhaled Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Devices for Inhaled Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Devices for Inhaled Medications Market Size by Application
10.2.1 Middle East and Africa Devices for Inhaled Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Devices for Inhaled Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Devices for Inhaled Medications Market Size by Country
10.3.1 Middle East and Africa Devices for Inhaled Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Devices for Inhaled Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Consort Medical
11.1.1 Consort Medical Corporation Information
11.1.2 Consort Medical Overview
11.1.3 Consort Medical Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Consort Medical Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Consort Medical Recent Developments
11.2 Inhalexper
11.2.1 Inhalexper Corporation Information
11.2.2 Inhalexper Overview
11.2.3 Inhalexper Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Inhalexper Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Inhalexper Recent Developments
11.3 Cambridge Consultants
11.3.1 Cambridge Consultants Corporation Information
11.3.2 Cambridge Consultants Overview
11.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cambridge Consultants Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cambridge Consultants Recent Developments
11.4 Hovione
11.4.1 Hovione Corporation Information
11.4.2 Hovione Overview
11.4.3 Hovione Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hovione Recent Developments
11.5 Catalent, Inc
11.5.1 Catalent, Inc Corporation Information
11.5.2 Catalent, Inc Overview
11.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Catalent, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Catalent, Inc Recent Developments
11.6 VertMarkets, Inc
11.6.1 VertMarkets, Inc Corporation Information
11.6.2 VertMarkets, Inc Overview
11.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 VertMarkets, Inc Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 VertMarkets, Inc Recent Developments
11.7 Qualicaps
11.7.1 Qualicaps Corporation Information
11.7.2 Qualicaps Overview
11.7.3 Qualicaps Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Qualicaps Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qualicaps Recent Developments
11.8 3M
11.8.1 3M Corporation Information
11.8.2 3M Overview
11.8.3 3M Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 3M Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 3M Recent Developments
11.9 Aerovance
11.9.1 Aerovance Corporation Information
11.9.2 Aerovance Overview
11.9.3 Aerovance Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aerovance Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aerovance Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Corporation Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Chiesi
11.12.1 Chiesi Corporation Information
11.12.2 Chiesi Overview
11.12.3 Chiesi Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Chiesi Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Chiesi Recent Developments
11.13 Cipla
11.13.1 Cipla Corporation Information
11.13.2 Cipla Overview
11.13.3 Cipla Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Cipla Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cipla Recent Developments
11.14 Civitas/Alkermes
11.14.1 Civitas/Alkermes Corporation Information
11.14.2 Civitas/Alkermes Overview
11.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Civitas/Alkermes Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Civitas/Alkermes Recent Developments
11.15 GlaxoSmithKline
11.15.1 GlaxoSmithKline Corporation Information
11.15.2 GlaxoSmithKline Overview
11.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 GlaxoSmithKline Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 GlaxoSmithKline Recent Developments
11.16 Hovione
11.16.1 Hovione Corporation Information
11.16.2 Hovione Overview
11.16.3 Hovione Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hovione Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hovione Recent Developments
11.17 Mannkind
11.17.1 Mannkind Corporation Information
11.17.2 Mannkind Overview
11.17.3 Mannkind Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mannkind Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mannkind Recent Developments
11.18 Mantecorp
11.18.1 Mantecorp Corporation Information
11.18.2 Mantecorp Overview
11.18.3 Mantecorp Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Mantecorp Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mantecorp Recent Developments
11.19 Meda
11.19.1 Meda Corporation Information
11.19.2 Meda Overview
11.19.3 Meda Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Meda Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Meda Recent Developments
11.20 MicroDose Therapeutx
11.20.1 MicroDose Therapeutx Corporation Information
11.20.2 MicroDose Therapeutx Overview
11.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 MicroDose Therapeutx Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 MicroDose Therapeutx Recent Developments
11.21 Novartis
11.21.1 Novartis Corporation Information
11.21.2 Novartis Overview
11.21.3 Novartis Devices for Inhaled Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Novartis Devices for Inhaled Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Devices for Inhaled Medications Industry Chain Analysis
12.2 Devices for Inhaled Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Devices for Inhaled Medications Production Mode & Process
12.4 Devices for Inhaled Medications Sales and Marketing
12.4.1 Devices for Inhaled Medications Sales Channels
12.4.2 Devices for Inhaled Medications Distributors
12.5 Devices for Inhaled Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Devices for Inhaled Medications Industry Trends
13.2 Devices for Inhaled Medications Market Drivers
13.3 Devices for Inhaled Medications Market Challenges
13.4 Devices for Inhaled Medications Market Restraints
14 Key Findings in The Global Devices for Inhaled Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer